Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Contravisory Investment Management Inc.

Contravisory Investment Management Inc. trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,092 shares of the medical equipment provider’s stock after selling 82 shares during the quarter. Contravisory Investment Management Inc.’s holdings in Intuitive Surgical were worth $570,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Brown Brothers Harriman & Co. grew its holdings in shares of Intuitive Surgical by 45.3% during the second quarter. Brown Brothers Harriman & Co. now owns 2,228 shares of the medical equipment provider’s stock worth $991,000 after buying an additional 695 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Intuitive Surgical by 10.2% during the second quarter. Dimensional Fund Advisors LP now owns 572,934 shares of the medical equipment provider’s stock worth $254,872,000 after acquiring an additional 52,976 shares during the period. One Capital Management LLC purchased a new stake in Intuitive Surgical in the 2nd quarter valued at approximately $790,000. Moors & Cabot Inc. increased its position in Intuitive Surgical by 2.3% during the 2nd quarter. Moors & Cabot Inc. now owns 1,159 shares of the medical equipment provider’s stock worth $516,000 after purchasing an additional 26 shares during the period. Finally, Sargent Investment Group LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $267,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 270 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock valued at $25,012,927 over the last quarter. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ISRG. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Raymond James raised their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. Finally, Wells Fargo & Company upped their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $580.11 on Thursday. The stock’s 50 day moving average price is $537.05 and its 200 day moving average price is $496.50. The firm has a market capitalization of $206.62 billion, a PE ratio of 93.27, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $355.17 and a one year high of $584.60.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. On average, analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.